Director/PDMR Shareholding

Paris, France and Camberley, UK – 18 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 12 November 2020, Anouska Penny-Gibson, a person closely associated (PCA) to Steve Gibson, a PDMR of Novacyt, acquired 697 ordinary shares of €1/15 each in the Company at an average price of £8.59 per share.  The resultant beneficial shareholding of Mr. Gibson is 9,116 ordinary shares representing 0.01% of the Company’s issued share capital.

https://novacyt.com/wp-content/uploads/2020/11/Novacyt-PCA-Dealings-APG-18.11.2020-ENGLISH-final.pdf